Current Assets
Derivative Assets - Fair Value
Medtronic Derivative Assets - Fair Value increased by 15.0% to $536.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 45.3%, from $980.00M to $536.00M. Over 4 years (FY 2021 to FY 2025), Derivative Assets - Fair Value shows an upward trend with a 34.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ4 2015
Last reportedQ3 2026Feb 24, 2026
How to read this metric
Higher values indicate successful hedging outcomes or favorable market shifts, whereas lower values suggest reduced hedging gains.
Detailed definition
This metric captures the total fair value of all derivative financial instruments that are currently in an asset positio...
Peer comparison
Highly comparable across energy and commodity-intensive firms that utilize extensive hedging programs.
Metric ID:
derivative_assets_fair_valueHistorical Data
20 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $102.00M | $160.00M | $254.00M | $326.00M | $695.00M | $907.00M | $1.08B | $341.00M | $368.00M | $421.00M | $720.00M | $549.00M | $659.00M | $668.00M | $589.00M | $980.00M | $334.00M | $335.00M | $466.00M | $536.00M |
| QoQ Change | — | +56.9% | +58.8% | +28.3% | +113.2% | +30.5% | +19.3% | -68.5% | +7.9% | +14.4% | +71.0% | -23.8% | +20.0% | +1.4% | -11.8% | +66.4% | -65.9% | +0.3% | +39.1% | +15.0% |
| YoY Change | — | — | — | — | +581.4% | +466.9% | +326.0% | +4.6% | -47.1% | -53.6% | -33.5% | +61.0% | +79.1% | +58.7% | -18.2% | +78.5% | -49.3% | -49.9% | -20.9% | -45.3% |
Range$102.00M – $1.08B
CAGR+41.8%
Avg YoY Growth+83.7%
Median YoY Growth-6.8%
Current Streak3 quarters growth
Derivative Assets - Fair Value at Other Companies
Frequently Asked Questions
- What is Medtronic's derivative assets - fair value?
- Medtronic (MDT) reported derivative assets - fair value of $536.00M in Q4 2025.
- How has Medtronic's derivative assets - fair value changed year-over-year?
- Medtronic's derivative assets - fair value decreased by 45.3% year-over-year, from $980.00M to $536.00M.
- What is the long-term trend for Medtronic's derivative assets - fair value?
- Over 4 years (2021 to 2025), Medtronic's derivative assets - fair value has grown at a 34.5% compound annual growth rate (CAGR), from $102.00M to $334.00M.
- What does derivative assets - fair value mean?
- The total market value of all derivative contracts that are currently profitable.